KIT and acute myeloid leukemia: In contrast, no similar E-selectin-mediated chemo-resistance was observed in normal BM KIT+ HSPC harvested from non-leukemic mice (Fig. 3b) confirming malignant AML blasts respond differently to E-selectin-adhesion compared to BM HPSC.